v3.26.1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2026
STOCKHOLDERS' EQUITY  
Schedule of common stock issued roll forward

The following table represents a share reconciliation of the Company’s common stock issued for the periods presented:

 

Three Months Ended March 31,

2026

2025

Common stock:

Balance, beginning of period

207,785,762

195,028,207

Shares issued for stock options exercised

7,894

56,412

Agent growth incentive stock-based compensation

632,274

446,657

Agent equity stock-based compensation

2,610,047

2,004,995

Other stock-based compensation

23,730

-

Balance, end of period

211,059,707

197,536,271

Changes in the Company's stock compensation liability

The following table illustrates changes in the Company’s stock-based compensation liability for the periods presented:

Amount

Balance, December 31, 2024

$ 5,045

Stock grant liability increase year to date

2,736

Stock grants reclassified from liability to equity year to date

(1,999)

Balance, December 31, 2025

$ 5,782

Stock grant liability increase year to date

968

Stock grants reclassified from liability to equity year to date

-

Balance, March 31, 2026

$ 6,750